EP4598512A1 — Immediate release oral pharmaceutical composition comprising linagliptin
Assigned to Santa Farma Ilac Sanayi AS · Expires 2025-08-13 · 1y expired
What this patent protects
The present invention relates to an oral immediate-release pharmaceutical composition comprising therapeutically effective amount of linagliptin or pharmaceutically acceptable forms or derivatives thereof. More specifically, the present invention relates to a solid oral dosage fo…
USPTO Abstract
The present invention relates to an oral immediate-release pharmaceutical composition comprising therapeutically effective amount of linagliptin or pharmaceutically acceptable forms or derivatives thereof. More specifically, the present invention relates to a solid oral dosage form manufactured by direct compression method presenting improved physicochemical characterizations along with release and impurity profiles.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.